Episode 131: Is This The Future of Medicine? An Expert Discussion With Drew Taylor
Are you wondering how to bank your stem cells for future use in a non-invasive way? If so, focus your attention towards Drew Taylor, the CEO of Acorn Biolabs. Acorn Biolabs is a company that provides the “first non-invasive solution to preserving your younger follicle cells for use in future cell treatments.” Drew has always been passionate about health science, and after playing professional baseball while simultaneously completing his Ph.D., he dedicated his professional career to researching tissue engineering and regenerative medicine.